颈动脉支架置入术后围手术期卒中患者的残疾及相关结局
基于血管质量倡议颈动脉支架置入登记(2016—2023年)中因无症状颈动脉疾病行经颈动脉血运重建(TCAR)或经股动脉颈动脉支架置入(TFCAS)的患者,评估术后卒中所致残疾程度及其与1年神经事件和死亡的关系。多数围手术期卒中患者遗留明显残疾,TFCAS后卒中者1年结局较TCAR后卒中者更差。
要点
- TCAR围手术期卒中率0.80%、卒中/死亡率1.03%,TFCAS分别为0.92%和1.19%。
- 术后严重残疾与1年死亡(HR 11.04)及后续神经事件/死亡(HR 10.82)风险升高相关。
- TFCAS后卒中者较TCAR后卒中者1年死亡和神经事件/死亡风险均升高(HR 1.27)。
核心结论
- 因无症状颈动脉疾病行TCAR和TFCAS后发生围手术期卒中的多数患者存在明显残疾,TFCAS后卒中者1年结局较TCAR后卒中者更差。
研究设计与样本
- 回顾性查询血管质量倡议颈动脉支架置入登记(2016—2023年)中因无症状疾病行CAS的病例。
- 术后卒中者的残疾按改良Rankin评分分层:0~1分为轻度、2~3分为中度、4~5分为重度、6分为死亡。
- 分析出院时记录的改良Rankin量表卒中相关残疾及其与长期结局的关联。
主要发现
- 因无症状疾病行TCAR共23435例、TFCAS共7487例。
- TCAR患者围手术期卒中率和卒中/死亡率分别为0.80%和1.03%,残疾分布为轻度33.6%、中度31.0%、重度28.9%、死亡7.5%。
- TFCAS患者围手术期卒中率和卒中/死亡率分别为0.92%和1.19%,残疾分布为轻度37.7%、中度31.0%、重度27.5%、死亡2.9%。
- 多变量分析显示术后早期重度残疾与1年死亡率升高(HR 11.04;95%CI 6.9-17.7;P = .001)及后续神经事件/死亡升高(HR 10.82;95%CI 6.93-16.9;P = .001)相关。
- TFCAS后卒中者较TCAR后卒中者1年死亡风险更高(HR 1.27;95%CI 1.10-1.47;P = .001),神经事件/死亡风险亦更高(HR 1.27;95%CI 1.11-1.45;P < .001)。
临床怎么用
- 作者认为这些发现有助于指导医患关于无症状颈动脉狭窄手术管理及CAS干预风险的讨论,并有助于术后卒中的预后判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Perioperative stroke after carotid artery stenting (CAS) is rare. However, the degree of disability and long-term effects from a postoperative stroke remain unclear. Our goal was to assess the degree of disability from a stroke after transcarotid artery revascularization (TCAR) and transfemoral CAS (TFCAS) for asymptomatic carotid artery disease, and the associated 1-year impact on subsequent neurological events and mortality. METHODS: The Vascular Quality Initiative CAS registry (2016-2023) was queried for CAS performed for asymptomatic disease. Patients with a postoperative stroke had their disability stratified by modified Rankin score of 0 to 1 (mild), 2 to 3 (moderate), 4 to 5 (severe), and 6 (deceased). Postoperative stroke-related disability based on modified Rankin scale for those recorded at discharge and its association with long-term outcomes were analyzed. RESULTS: There were 23,435 TCAR and 7487 TFCAS procedures performed for asymptomatic disease. Among TCAR patients, the periprocedural stroke and stroke/death rates were 0.80% and 1.03%, respectively, with disability distributed as 33.6% mild, 31.0% moderate, 28.9% severe, and 7.5% deceased. Among TFCAS patients, the periprocedural stroke and stroke/death rates were 0.92% and 1.19%, respectively, with disability distributed as 37.7% mild, 31.0% moderate, 27.5% severe, and 2.9% deceased. Multivariable analysis demonstrated that severe early postoperative disability was associated with increased 1-year mortality (hazard ratio [HR], 11.04; 95% confidence interval [CI], 6.9-17.7; P = .001) and increased subsequent neurological event/death (HR, 10.82; 95% CI, 6.93-16.9; P = .001). Patients with a stroke after TFCAS had a higher risk of 1-year mortality (HR, 1.27; 95% CI, 1.10, 1.47; P = .001) and neurological event/death (HR, 1.27; 95% CI, 1.11-1.45; P < .001), as compared with patients with a stroke after TCAR. Among patients who undergo a CAS procedure for asymptomatic disease, hypertension was associated with a higher likelihood of developing severe disability (odds ratio [OR], 4.2; 95% CI, 1.03-17.32; P = .045), whereas preoperative aspirin (OR, 0.51; 95% CI, 0.30-0.87; P = .01) or P2Y12 inhibitor use (OR, 0.45; 95% CI, 0.27-0.74; P = .11) was associated with a lower likelihood of developing a severe disability. CONCLUSIONS: The majority of patients who undergo TCAR and TFCAS for asymptomatic carotid artery disease who suffered a periprocedural stroke had substantial disability. Patients with strokes from TFCAS have worse 1-year outcomes as compared with patients with stroke after TCAR. These findings should help to guide patient-provider discussions regarding the surgical management of asymptomatic carotid stenosis and the risks of CAS interventions, as well as aid in the prognostication of postoperative stroke.
引用
- Alonso A, Kobzeva-Herzog AJ, Levin SR, et al. Disability and associated outcomes among patients suffering periprocedural strokes after carotid artery stenting. J Vasc Surg. 2025. PMID: 39923916. doi:10.1016/j.jvs.2025.01.223
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。